A method was developed for the simultaneous determination of selenomethionine (SeMet) and selenocysteine (SeCys) in meat (chicken and lamb muscles) and different offal tissues (heart, liver, kidney). The analytical procedure was based on the protein extraction with urea under reducing conditions (dithiothreitol), derivatization of SeCys and SeMet by carbamidomethylation with iodoacetamide (IAM) followed by quantitative proteolysis. The mixture of the derivatized Se-amino acids was purified by size-exclusion liquid chromatography (LC) and analysed by ion-paring reversed-phase HPLC-inductively coupled plasma mass spectroscopy (ICP MS). The quantification of SeCys and SeMet was carried out by the method of standard additions. (77)SeMet was used to control the SeMet derivatization efficiency and recovery. The method was validated by the determination of the Se mass balance. The Se-amino acids accounted for 91 +/- 8% of the total selenium (mean of 95 samples of seven tissues analysed over a period of 18 months). The method was applied to the discrimination of the contribution of selenoproteins (containing SeCys) and other Se-containing proteins (containing SeMet) in tissues of animals during supplementation studies (dose-effect and tolerance).
A systematic approach to the characterization of selenized yeast supplements in terms of the speciation of selenium was developed. The optimized fractionation procedures included the sequential leaching of water soluble, cell-wall bound, and membrane-protein selenium followed by a further fractionation of each extract by high-resolution size-exclusion chromatography. The stability of fractions collected as chromatographic peaks was investigated in the presence of a proteolytic enzyme (pronase XIV) and trypsin in order to discriminate between selenium-containing peptides and other selenocompounds. Reversed-phase HPLC of tryptic digests of size-exclusion chromatographic fractions allowed the identification of selenopeptides by MALDI and electrospray MS. The complexity of the speciation of the water-soluble selenium in yeast was confirmed. Surprisingly, selenomethionine in the water insoluble fraction was found to be bound physically to cell wall constituents rather than being incorporated chemically into the protein structure, in contrast to former studies.
A new method was proposed for speciation analysis for selenium metabolites in Se-rich yeast. The coupling of a normal bore (4.6 mm) hydrophilic interaction liquid chromatography (HILIC) column with a hybrid linear ion trap/orbital ion trap mass spectrometer allowed the detection of the selenium-isotopic pattern in mass spectra down to the intrascan abundance of 0.001 with the low- and sub-part per million (ppm) mass accuracy regardless of the concentration. The quantitative elution recovery was verified by online ICPMS. The confirmation that all the species present were found was achieved by the parallel use of anion-exchange HPLC-ICPMS optimized for the maximum resolution. The species with intrascan abundance of at least 0.005 produced a cascade of product ion mass spectra to at least MS (4) with the preservation of the selenium isotopic pattern and the sub-ppm mass accuracy, which largely facilitated the structure elucidation. The approach was successfully applied to the characterization of nine (all which were present in the analyzed sample) selenium species in one chromatographic run.
A method was developed for the identification of selenium-containing peptides issued from proteins of a Se-rich (82.9 mg kg À1 ) foodstuff, Brazil nut (Bertholletia excelsa). A sample purification procedure was optimized to cope with the 100-fold excess of sulfur analogues and matrix interferences. It was based on the consecutive size-exclusion fractionation of proteins and tryptic peptides, and enrichment of the Se-containing fractions, prior to nanoHPLC-ES-Q/TOF MS/MS. The characteristic isotopic patterns of selenium compounds (always minor peaks) were detected in ESI mass spectra at retention times precisely indicated by the matrix interference-free, sensitive (DL 1.3 fmol) 80 Se detection by ICP collision cell MS in the same separation conditions. The potential of the method was demonstrated by the identification of 15 Se-containing peptides, from which all but one were found to originate from the selenised isoforms of the 2S protein.
Sample preparation methods based on the use of proteolytic and cell wall digesting enzymes for the speciation analysis of selenized mushroom were investigated. The sample (Agaricus bisporus; 160 microg total Se per g sample) was grown on compost supplemented with selenized yeast. Experiments were carried out to elucidate the possible role of the cell wall digesting enzymes--Lysing enzyme and Driselase--in the improvement of extraction efficiency with and without inhibiting proteolysis during cell wall digestion. A 3-step procedure applying Lysing enzyme and pronase gave the highest extraction efficiency (89%); however, the best species recovery was achieved by a one-step proteolytic procedure. All the procedures of selenium speciation were controlled by independent ICP-AES analysis measuring the total amount of selenium.
A three-step chromatographic procedure using orthogonal separation mechanisms (size-exclusion, cation-exchange and ion-pairing reversed phase) was developed to purify three low molecular weight selenospecies, including the major compound, from the aqueous extract of monkeypot (Lecythis minor) nuts. The following reversed-phase nanoHPLC-electrospray Q-TOF-MS/MS allowed the formal standardless identification of selenocystathionine and two isoforms of gamma-glutamyl-selenocystathionine. This is the first MS and MS/MS-based formal evidence of the presence of these compounds in a biological sample.
An analytical approach allowing the identification of unknown selenium metabolites in selenium-rich yeast was described. Anion-exchange HPLC of the Se-metabolome fraction co-eluting with salts in size-exclusion chromatography allowed the separation of nine selenium species (excluding isomers and selenate) as monitored by inductively coupled plasma mass spectrometry (ICP MS). The individual fractions were analyzed by electrospray QTOF MS/MS and hybrid linear ion trap/Orbitrap MSn after sample introduction by reversed-phase nanoHPLC and by hydrophilic interaction LC (HILIC), respectively. Out of the nine detected species, eight were identified on the basis of accurate mass measurements and collision induced dissociation/fragmentation information. Seven Se-species (selenohomolanthionine, γ-Glu-selenocystathionine, 2,3-DHP-selenocystathionine, N-acetyl-selenocystathionine, 2,3-DHP-selenohomolanthionine, Se-methyl-selenoglutathione, and 2,3-DHP-Se-methylselenocysteine) were reported for the first time in Se-rich yeast, five of them have never been reported in any biological sample before.
Size-exclusion chromatography (SEC)-strong anion-exchange (SAX) HPLC fractionation of selenium species from the aqueous extract of a selenised yeast sample was optimised under the strict selenium mass balance control by ICP-MS. The SAX HPLC-ICP-MS chromatogram of the most intense SEC fraction produced seven peaks. They were all successfully identified by reversed phase (RP) nanoHPLC-electrospray Q-TOFMS/MS. Eight Se-compounds (derivatives of glutathione) were identified: six of them have not been reported previously. Six of the identified compounds contained selenocysteine (28% of the water-soluble selenium), stabilised by either Se-S or Se-Se bridges. The extensive MS/MS data presented are potentially useful for the optimization of direct LC-ESIMS/MS analyses in the selected (SRM) or multiple (MRM) reaction monitoring modes for the purpose of the authenticity and quality control of Se-rich yeast supplements.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.